![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1645, 2008-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib for multiple myeloma
By Popat Rakesh Joel Simon Oakervee Heather Cavenagh Jamie
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib battles the front line in multiple myeloma
Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bortezomib: A Review of its Use in Patients with Multiple Myeloma
By Curran Monique P. McKeage Kate
Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. :